| 图片 | 名称及描述 | |
|---|---|---|
|
Oxalyl bromide
97%
|
||
|
OH-(C3H6O)5-NH2
|
||
|
O-(2-Methoxyisopropyl)hydroxylamine
97%
|
||
|
OH-(C3H6O)7-NH2
|
||
|
OL-135
98%
|
||
|
Olean-13(18)-en-28-oic acid, 2,3,16,23-tetrahydroxy-, (2β,3β,4α,16α)-
97%
|
||
|
octahydropyrazino[2,1-c][1,4]oxazine-6,9-dione
97%
|
||
|
o-Tolidine dihydrochloride
97%
|
||
|
Octadecyl 3-(3-tert-butyl-4-hydroxyphenyl)propanoate
97%
|
||
|
Oxo-[3-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-acetic acid
97%
|
||
|
Oxazole, 2-(2-chlorophenyl)-5-methoxy-4-(phenylsulfonyl)-
97%
|
||
|
Osimertinib-d
97%
|
||
|
Oxazolo[4,5-b]pyridin-2(3H)-one,3-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-
97%
|
||
|
Orexin receptor antagonist 2
97%
|
||
|
Oxazole, 2-(4-chlorophenyl)-4,5-dihydro-
|
||
|
oxalylbis(4,1-phenylene) bis(oct-7-enoate)
97%
|
||
|
Oseltamivir acid-d
97%
|
||
|
O1-tert-butyl O3-ethyl 3-(iodomethyl)azetidine-1,3-dicarboxylate
97%
|
||
|
Oxazol-4-ylboronic acid
97%
|
||
|
OUL245
97%
|

